Pluger, E.B., Boes, M., Alfonso, C., Schroter, C.J., Kalbacher, H., Ploegh, H.L., and Driessen, C.: Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 2002, 32:467–476.
6-7 The invariant chain directs newly synthesized MHC class II molecules to acidified intracellular vesicles.
Gregers, T.F., Nordeng, T.W., Birkeland, H.C., Sandlie, I., and Bakke, O.: The cytoplasmic tail of invariant chain modulates antigen processing and presentation. Eur. J. Immunol. 2003, 33:277–286.
Hiltbold, E.M., and Roche, P.A.: Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol. 2002, 14:30–35.
Kleijmeer, M., Ramm, G., Schuurhuis, D., Griffith, J., Rescigno, M., Ricciardi-Castagnoli, P., Rudensky, A.Y., Ossendorp, F., Melief, C.J., Stoorvogel, W., et al.: Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 2001, 155:53–63.
van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H., Reits, E., Pastoors, L., and Neefjes, J.: Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 2001, 167:884–892.
6-8 The MHC class II-like molecules HLA-DM and HLA-DO regulate exchange of CLIP for other peptides.
Alfonso, C., and Karlsson, L.: Nonclassical MHC class II molecules. Annu. Rev. Immunol. 2000, 18:113–142.
Apostolopoulos, V., McKenzie, I.F., and Wilson, I.A.: Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design. Front. Biosci. 2001, 6:D1311–D1320.
Buslepp, J., Zhao, R., Donnini, D., Loftus, D., Saad, M., Appella, E., and Collins, E.J.: T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface. J. Biol. Chem. 2001, 276:47320–47328.
Gu, Y., Jensen, P.E., and Chen, X.: Immunodeficiency and autoimmunity in H2-O-deficient mice. J. Immunol. 2013, 190:126–137.
Hill, J.A., Wang, D., Jevnikar, A.M., Cairns, E., and Bell, D.A.: The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLADRβ1*0401 transgenic mouse model. Arthritis Res. Ther. 2003, 5:R40–R48.
Mellins, E.D., and Stern, L.J.: HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation. Curr. Opin. Immunol. 2014, 26:115–122.